Production (Stage)
Tango Therapeutics, Inc.
TNGX
$1.84
-$0.025-1.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.17% | -22.45% | -31.01% | -23.38% | -35.37% |
| Total Depreciation and Amortization | -0.48% | 0.49% | 1.47% | 4.64% | 7.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.92% | 120.18% | 6.14% | 41.92% | 48.87% |
| Change in Net Operating Assets | -46.63% | -852.93% | 26.47% | 37.03% | 41.55% |
| Cash from Operations | -10.14% | -33.42% | -7.24% | 3.54% | -8.45% |
| Capital Expenditure | 73.85% | 45.13% | -618.75% | 51.81% | 68.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 378.42% | 53.13% | 157.70% | -60.96% | -134.22% |
| Cash from Investing | 373.11% | 53.79% | 157.48% | -61.15% | -135.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -43.27% | -97.01% | 123.72% | 58,779.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -33.95% | -97.01% | 123.72% | 58,779.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.59% | 108.63% | 121.04% | -209.06% | -85.14% |